Navigation Links
Many Women Can Have Cervical Cancer Test Every 3 Years: Study
Date:5/19/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, May 18 (HealthDay News) -- Women 30 and older who have good results from each of the two cervical cancer tests available today can safely wait three years for their next screening instead of just one year, according to new research.

The finding is not likely be controversial, said Dr. Charles Capen, chief of gynecology/oncology at Scott & White Healthcare in Temple, Texas, given that most current guidelines already recommend that women 30 and over who are otherwise healthy be screened with both a Pap smear and a test for a virus linked to cervical cancer every three years as long as the initial tests are both negative.

Unlike some cancers, cervical cancer is usually slow-growing, and it is curable if detected early, according to the U.S. National Cancer Institute.

"This [new research] confirms the latest guidelines," agreed Dr. Therese Bevers, medical director of the Cancer Prevention Center at the University of Texas M.D. Anderson Cancer Center in Houston. "That is fabulous as it can give clinicians and women everywhere a lot of reassurance."

Hopefully, it will also spur more doctors to actually follow these guidelines, added Bevers, as recent research has revealed that most doctors are giving the Pap test more often than recommended -- i.e., once a year.

The study findings will be presented at the annual meeting of the American Society of Clinical Oncology being held in June in Chicago. The results were released early Wednesday during a teleconference.

Cervical cancer risk can be assessed by two different tests: the traditional Pap smear, which searches for abnormalities in cervical cells, and a newer test that can detect DNA of the virus that causes most cases of cervical cancer: human papillomavirus, or HPV. That screening is referred to as the HPV test.

The new study involved more than 330,000 women enrolled in a large northern California health plan who were undergoing both types of tests between 2003 and 2005 and who were followed for five years after being tested.

The estimated five-year risk for developing cervical cancer was 7.5 per 100,000 women in those who had normal Pap smears, versus a much lower 3.8 per 100,000 for women who were negative on the HPV test.

When the two tests were performed together with both yielding negative results, the estimated risk was 3.2 per 100,000 women, meaning that the HPV test alone is almost as good as the two combined.

"A single negative HPV test [predicted] an extremely low cancer risk for women [which] was not appreciably lowered by having a normal Pap test," said lead author Hormuzd Katki, principal investigator in the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute.

That means that women who test negative on the HPV test alone might be able to extend their screening intervals to three years with no adverse consequences, Katki added.

"This generates the question, should HPV testing become the standard at some point," Bevers said.

This might be especially important in developing countries that often don't have the capability to interpret Pap tests, Bevers said.

"HPV testing is much easier," she added. "It's kind of like doing a pregnancy test at home. It's positive or negative."

There is still a role, however, for the Pap test -- to follow up a positive HPV test, said Katki. "The Pap test can identify women who have more immediate disease," he said.

"But many women equate a Pap smear with their annual gynecological exam and one of the arguments against three-year screening intervals is that women would no longer see their doctor every year and get other necessary tests, such as blood pressure, cholesterol and testing for sexually transmitted infections," Capen said.

Capen, though, thinks that won't happen. "Young women may be on the pill or they may be pregnant, so hopefully they will still get the medical care they need," he said.

Since the study findings are to be presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.

More information

There's more on cervical cancer screening at the U.S. Centers for Disease Control and Prevention.

SOURCES: Charles Capen, M.D., chief of gynecology/oncology, Scott & White Healthcare, Temple, Texas; Therese Bevers, M.D., medical director, Cancer Prevention Center, University of Texas M.D. Anderson Cancer Center, Houston; May 18, 2011, teleconference with Hormuzd Katki, Ph.D., principal investigator, division of cancer epidemiology and genetics, U.S. National Cancer Institute; U.S. National Cancer Institute study abstract, May 18, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Exercise helps women fight smoking cravings, but effect is short-lived
2. New commitments to save women and children
3. Smoking Raises Odds for Cancer in Women Already at High Risk
4. Recurring cancers in women with a history of breast cancer differ from the original tumors
5. Are Affluent Women More Apt to Choose C-Section?
6. Abortions generate $95 million a year for Polish doctors as women use illegal private sector
7. EMAS publishes position statement about the post-reproductive health of women
8. Women & Infants receives support from CVS Caremark Charitable Trust
9. Gene variation linked to infertility in women, study finds
10. For Some Women, Knowing About Heart Failure Spurs Worry
11. Health reform law will insure nearly all uninsured women by 2014
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Women Can Have Cervical Cancer Test Every 3 Years: Study 
(Date:1/22/2017)... , ... January 22, 2017 , ... Zifam Pinnacle, an ... the world, recently met with big-name retail buyers at the January ECRM Trade Show ... efficacy and uses the utmost safety standards in all of its creations to help ...
(Date:1/21/2017)... FL (PRWEB) , ... January 21, 2017 , ... Caronlab ... recently attended the January ECRM Trade Show in Hilton Head, SC, where it benefited ... reputation for the quality of its beauty and wellness products. At this trade show, ...
(Date:1/21/2017)... ... 21, 2017 , ... Seamild, the largest manufacturer of oats in China, is ... and founder. As Oat is recognized globally as one of the healthiest cereals, XieQingkui, ... believes it is a move to sow the seed of good karma. Buddhism spirit ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical Associates (NCMA) ... their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient surgery, ... add this excellent dermatology practice to our group’s medical services,” explains NCMA CEO, ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
(Date:1/20/2017)... Research and Markets has announced the addition of ... OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast ... ... Sales Volume, Company Analysis and Forecast to 2022 provides a ... The growing prevalence of hearing impairment coupled with an ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Pharmaceuticals Inc. (NASDAQ: SGYP ), Novo Nordisk A/S ... SCMP ), and Pernix Therapeutics Holdings Inc. (NASDAQ: ... which fell on Thursday, January 19 th , 2017, finishing ... NYSE Health Care Index dropped over 0.7%, while shares of ...
Breaking Medicine Technology: